Benitec Biopharma
BNTC
BNTC
7 hedge funds and large institutions have $1.23M invested in Benitec Biopharma in 2018 Q3 according to their latest regulatory filings, with 2 funds opening new positions, 1 increasing their positions, 3 reducing their positions, and 1 closing their positions.
Holders
7
Holders Change
+1
Holders Change %
+16.67%
% of All Funds
0.16%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
2
Increased
1
Reduced
3
Closed
1
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
SFM
1
Sphera Funds Management
Tel Aviv,
Israel
|
$294K |
| 2 |
2
Citadel Advisors
Miami,
Florida
|
$30K |
| 3 |
3
Morgan Stanley
New York
|
$141K |
| Name | Market Value | Shares |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
|
HCM
1
Highbridge Capital Management
New York
| $647K | 273,010 | -497,770 | -65% |
|
|
SFM
2
Sphera Funds Management
Tel Aviv,
Israel
| $294K | 120,000 | +120,000 | New |
|
|
3
Morgan Stanley
New York
| $141K | 59,300 | +8,500 | +17% |
|
4
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
| $84K | 34,348 | -34,392 | -50% |
|
5
Renaissance Technologies
New York
| $32K | 13,700 | – | – |
|
|
6
Citadel Advisors
Miami,
Florida
| $30K | 12,067 | +12,067 | New |
|
7
UBS Group
Zurich,
Switzerland
| $5K | 2,117 | -1,644 | -44% |
|
|
WS
8
Wedbush Securities
Los Angeles,
California
| – | – | -20,000 | Closed |
|
|
CFGS
9
Concourse Financial Group Securities
Birmingham,
Alabama
| – | – | – | – |
|